Last reviewed · How we verify

NCT03627793

Resistance Exercise Training at Different Intensities in Healthy and Frail Older People: A Feasibility Study

Status unknown NA Last updated 11 October 2018
What this trial tests

NA trial testing resistance training in Frail Elderly Syndrome in 60 participants. Status unknown.

Timeline
21 August 2018
Primary endpoint
29 November 2019
29 November 2019

Quick facts

Lead sponsorUniversity of Glasgow
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date21 August 2018
Primary completion29 November 2019
Estimated completion29 November 2019
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Glasgow

Who can join

65 and older, any sex, with Frail Elderly Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

After the age of 40-45 years muscle mass and function progressively decline, reducing older peoples' abilities to perform tasks of daily living and also increase the risk of falls. It is known that, across the life course, resistance exercise can be of benefit in increasing muscle mass and function, yet how hard the exercise should be performed has received little attention. Current recommendations are for older people to perform exercise at 70% of the maximum they can lift, quite a high intensity that often puts older people off participating. Recent evidence in younger people has suggested that such intensities are not required. The investigators aim to determine the feasibility of a study to investigate recruitment and adherence of older people to a study of exercise training at different intensities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of resistance training

Trials testing the same drug.

Other recruiting trials for Frail Elderly Syndrome

Currently open trials in the same condition.

Other University of Glasgow trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03627793.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing